Clinical Trials Begin for Multiple Sclerosis Therapy
May 31, 2025
The Diaprotectome therapy for Multiple Sclerosis is set to begin human clinical trials after promising results in animal testing. Its goal is to slow down, and potentially restore, nerve function in patients. Greece's involvement in this research is significant and may also include Cypriot patients in the future. The new therapy is considered safe and aims to fill a gap in existing treatments.